4,7-Dichloroquinazoline is a heterocyclic organic compound characterized by its quinazoline structure, which consists of a fused benzene and pyrimidine ring system. The presence of two chlorine atoms at the 4 and 7 positions of the quinazoline ring significantly influences its chemical properties and reactivity. This compound is typically a crystalline solid and is known for its potential applications in medicinal chemistry, particularly as a scaffold for developing pharmaceuticals due to its biological activity. It may exhibit properties such as antimicrobial, anti-inflammatory, or anticancer effects, depending on the specific substitutions and modifications made to its structure. Additionally, 4,7-Dichloroquinazoline is soluble in organic solvents, which facilitates its use in various chemical reactions and synthesis processes. Safety considerations should be taken into account when handling this compound, as halogenated compounds can pose environmental and health risks. Overall, 4,7-Dichloroquinazoline serves as an important compound in research and development within the field of organic and medicinal chemistry.

4,7-Dichloroquinazoline

4,7-Dichloroquinazoline is a reactive compound that can be used as a reactant in the palladium-catalyzed cross-coupling reaction. The product of this reaction is an epidermal growth factor (EGF). 4,7-Dichloroquinazoline has been shown to stimulate the production of EGF by wild-type EGFR cells and tyrosine kinase. This compound also inhibits phosphatases and hydrogen bonding interactions with proteins.

CAS 2148-57-4: 4,7-Dichloroquinazoline

4,7-Dichloroquinazoline

Ref: 54-OR951087

4,7-Dichloroquinazoline

Ref: 3D-FD36067

4,7-Dichloroquinazoline

Ref: 10-F093198

4,7-Dichloroquinazoline

Ref: IN-DA00715V